These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21252694)

  • 1. Influence of aetiology on long-term effects of resynchronization on cardiac structure and function in patients treated with β-blockers.
    Zacà V; Baiocchi C; Gaddi R; Gentilini R; Lunghetti S; Padeletti M; Pagliaro A; Furiozzi F; Mondillo S; Favilli R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):227-33. PubMed ID: 21252694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.
    St John Sutton M; Ghio S; Plappert T; Tavazzi L; Scelsi L; Daubert C; Abraham WT; Gold MR; Hassager C; Herre JM; Linde C;
    Circulation; 2009 Nov; 120(19):1858-65. PubMed ID: 19858419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.
    Knappe D; Pouleur AC; Shah AM; Bourgoun M; Brown MW; Foster E; Pfeffer MA; Moss AJ; Solomon SD;
    J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure.
    Mangiavacchi M; Gasparini M; Faletra F; Klersy C; Morenghi E; Galimberti P; Genovese L; Regoli F; De Chiara F; Bragato R; Andreuzzi B; Pini D; Gronda E
    Am Heart J; 2006 Feb; 151(2):477.e1-477.e6. PubMed ID: 16442917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
    Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.
    St John Sutton MG; Plappert T; Abraham WT; Smith AL; DeLurgio DB; Leon AR; Loh E; Kocovic DZ; Fisher WG; Ellestad M; Messenger J; Kruger K; Hilpisch KE; Hill MR;
    Circulation; 2003 Apr; 107(15):1985-90. PubMed ID: 12668512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes after cardiac resynchronization therapy: importance of left ventricular diastolic function and origin of heart failure.
    Waggoner AD; Rovner A; de las Fuentes L; Faddis MN; Gleva MJ; Sawhney N; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Mar; 19(3):307-13. PubMed ID: 16500494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of cardiac resynchronization therapy response: value of calibrated integrated backscatter imaging.
    Bertini M; Delgado V; den Uijl DW; Nucifora G; Ng AC; van Bommel RJ; Borleffs CJ; Boriani G; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):86-93. PubMed ID: 19920028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy.
    Soliman OI; van Dalen BM; Theuns DA; ten Cate FJ; Nemes A; Jordaens LJ; Geleijnse ML
    J Diabetes Complications; 2009; 23(5):365-70. PubMed ID: 18572420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management.
    Nabeta T; Inomata T; Iida Y; Ikeda Y; Iwamoto-Ishida M; Ishii S; Naruke T; Mizutani T; Shinagawa H; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Jul; 31(7):1109-16. PubMed ID: 26253941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between acute improvement in left ventricular function to 6-month outcomes after cardiac resynchronization therapy in patients with chronic heart failure.
    Pires LA; Ghio S; Chung ES; Tavazzi L; Abraham WT; Gerritse B
    Congest Heart Fail; 2011; 17(2):65-70. PubMed ID: 21449994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cardiac resynchronization therapy on left ventricular diastolic function assessed with speckle-tracking echocardiography.
    Shanks M; Antoni ML; Hoke U; Bertini M; Ng AC; Auger D; Marsan NA; van Erven L; Holman ER; Schalij MJ; Bax JJ; Delgado V
    Eur J Heart Fail; 2011 Oct; 13(10):1133-9. PubMed ID: 21873339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of time course of response to cardiac resynchronization therapy in patients with ischemic versus nonischemic cardiomyopathy.
    Marsan NA; Bleeker GB; van Bommel RJ; Ypenburg C; Delgado V; Borleffs CJ; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2009 Mar; 103(5):690-4. PubMed ID: 19231335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy allows the optimization of medical treatment in heart failure patients.
    Kachboura S; Ben Halima A; Ibn Elhadj Z; Marrakchi S; Chrigui R; Kammoun I; Chine S; Lefi A
    Ann Cardiol Angeiol (Paris); 2014 Feb; 63(1):17-22. PubMed ID: 23932251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiology.
    Soliman OI; Theuns DA; ten Cate FJ; Anwar AM; Nemes A; Vletter WB; Jordaens LJ; Geleijnse ML
    Am J Cardiol; 2007 Aug; 100(3):464-9. PubMed ID: 17659930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
    Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume overload modulates effects of cardiac resynchronization therapy independently of myocardial reperfusion: results of the RESYNC study.
    Gimelli A; Stanislao M; Valle G; Frumento P; Zanco P; Ometto R; Inglese E; Martino G; Startari U; Bertelli P; Marzullo P
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):575-81. PubMed ID: 17667027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.